Roche's Q1 MDx Sales Drop 3 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Roche today reported that its sales for its molecular diagnostics products fell 3 percent for the first quarter as revenues for its Diagnostics Division overall grew 1 percent.

The Swiss diagnostics, pharmaceuticals, and research products firm reported total group sales of CHF 11.59 billion ($12.45 billion), up 5 percent year over year, and driven by its pharmaceutical products sales, which rose 6 percent to CHF 9.17 billion from CHF 8.62 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.